Barton, M. B. et al. Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 112, 140–144 (2014). - ‘Radiation is used in approximately 50% of all cancer treatments1. The key objective in cancer radiotherapy is to achieve a high therapeutic efficacy by maximizing damage to the tumor whilst minimizing damage to surrounding healthy tissue2,3,4. In conventional external beam radiotherapy, the dose that can be delivered to a tumor is often limited by the presence of an adjacent critical organ. This means that not all tumor cells may receive a lethal dose of radiation, thus limiting the treatment efficacy.’
- Forums
- ASX - By Stock
- OSL
- Ann: OncoSil AGM CEO Presentation
Ann: OncoSil AGM CEO Presentation, page-107
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.5¢ |
Change
0.002(15.4%) |
Mkt cap ! $56.76M |
Open | High | Low | Value | Volume |
1.3¢ | 1.5¢ | 1.3¢ | $76.04K | 5.442M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 450000 | 1.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.5¢ | 9713598 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 450000 | 0.014 |
12 | 9692597 | 0.013 |
16 | 8588749 | 0.012 |
23 | 11307036 | 0.011 |
20 | 12558634 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.015 | 9713598 | 7 |
0.016 | 4183334 | 3 |
0.017 | 5088882 | 2 |
0.018 | 1532208 | 3 |
0.019 | 200000 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |